A PHASE 1, OPEN-LABEL, RANDOMIZED, THREE-PERIOD, THREE-TREATMENT, BALANCED, SIX-SEQUENCE CROSSOVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF DIFFERENT HYDROMETHYLTHIONINE MESYLATE (HMTM) TABLET FORMULATIONS AND STRENGTHS IN HEALTHY ADULT SUBJECTS.
This study is looking at a new medicine called hydromethylthionine mesylate (HMTM), which could potentially help people with conditions like Alzheimer's disease. We are testing different forms and strengths of this medicine in healthy adult volunteers to understand how well the body absorbs and uses each one. The main goal is to compare these different versions to find the most effective and safe way to deliver the medicine. By doing this research, we hope to improve treatments in the future. This is an early-stage study, meaning it's focused on understanding the medicine itself, rather than directly treating a disease yet.
At a glance
What is this study about?
This research is an early-stage study, sometimes called a Phase 1 study, focusing on a new medicine named hydromethylthionine mesylate, or HMTM for short. We're interested in how this medicine might one day help people with conditions like Alzheimer's disease. However, this particular study doesn't involve people with Alzheimer's.
Instead, we are inviting healthy adult volunteers to help us understand how different forms and strengths of the HMTM tablet are handled by the body. Think of it like comparing different brands or types of a vitamin – we want to see if a tablet taken by mouth is absorbed into the bloodstream in the same way, or if one version gets into the body better than another. This is really important because how well a medicine is absorbed affects how effective it can be.
The study is designed in a special way called a 'crossover' study. This means that each participant will try a few different versions of the medicine at different times, with breaks in between. This helps us get a very clear picture of how each version works within the same person, making the results more reliable and reducing the number of people needed for the study. The information we gather will help researchers choose the best way to develop this medicine further for future studies that might involve patients.
Key takeaways
- This is an early study testing a new medicine called HMTM.
- It's for healthy adults, not people with conditions like Alzheimer's.
- The study aims to see how different forms of the medicine are absorbed by the body.
- Participation involves multiple visits and blood tests over several weeks.
- You won't directly benefit, but you'll help advance medical research.
Who may be eligible?
To join this study, we are looking for healthy adults. This means you should generally be in good health and not have any serious or ongoing medical conditions that might affect the study results or your safety.
You must be at least 18 years old to take part. There isn't an upper age limit mentioned, so if you're an adult and meet the other health criteria, you could be eligible.
Both men and women are welcome to participate. The study team will review your medical history and conduct some checks to make sure this study is right for you.
- Are you 18 years old or older?
- Are you generally in good health?
- Are you willing to visit the study site multiple times?
- Are you comfortable with having blood samples taken regularly?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you join this study, you'll be one of the healthy volunteers helping us learn about this new medicine. The study is designed in 'periods,' meaning you will visit a medical facility multiple times. During these visits, you will receive different versions or strengths of the HMTM medicine. There will be breaks, called 'washout periods,' between receiving the different versions to allow the medicine to leave your body.
Throughout your participation, the study team will take blood samples to measure how much of the medicine is in your system. They will also do regular health checks, such as measuring your blood pressure, temperature, and looking for any side effects. You'll be asked to follow specific instructions, like what you can eat or drink before visits. The total duration of your involvement could span several weeks or even a few months, depending on the number of periods and washout times required.
Potential risks and benefits
Locations (1)
- —Netherlands
Common questions
What is hydromethylthionine mesylate (HMTM)?
It's a new medicine being tested that might one day help people with conditions like Alzheimer's disease. This study is helping us understand it better.
Will I get the actual medicine or a dummy pill?
In this study, you will receive different versions and strengths of the active medicine (HMTM) at different times, not a dummy pill (placebo).
How long will I need to be involved in the study?
The study involves multiple visits over several weeks or a few months, with breaks in between the different medication periods.
Will my health be checked during the study?
Yes, your health will be regularly monitored with blood tests and other checks to make sure you are safe and well.
Do I need to have Alzheimer's disease to join?
No, this specific study is for healthy adult volunteers, not people with Alzheimer's disease.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.